13.64
0.25 (1.87%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Mind Medicine (MindMed) Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.10 |
|
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD). |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.85% |
| 机构持股比例 | 55.15% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 61.00 (Jones Trading, 347.21%) | 购买 |
| 中 | 26.50 (94.28%) | |
| 低 | 20.00 (RBC Capital, 46.63%) | 购买 |
| 平均值 | 33.50 (145.60%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 12.42 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Jones Trading | 23 Dec 2025 | 61.00 (347.21%) | 购买 | 14.02 |
| Canaccord Genuity | 07 Nov 2025 | 25.00 (83.28%) | 购买 | 11.70 |
| RBC Capital | 07 Nov 2025 | 20.00 (46.63%) | 购买 | 11.70 |
| Needham | 13 Oct 2025 | 28.00 (105.28%) | 购买 | 12.25 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BARROW ROBERT | - | 13.06 | -25,791 | -336,830 |
| KARLIN DANIEL | - | 13.06 | -5,600 | -73,136 |
| SULLIVAN MARK | - | 13.06 | -11,276 | -147,265 |
| 累积净数量 | -42,667 | |||
| 累积净值 ($) | -557,231 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 13.06 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| SULLIVAN MARK | 职员 | 26 Dec 2025 | 自动卖出 (-) | 11,276 | 13.06 | 147,265 |
| BARROW ROBERT | 职员 | 26 Dec 2025 | 自动卖出 (-) | 25,791 | 13.06 | 336,830 |
| KARLIN DANIEL | 职员 | 26 Dec 2025 | 自动卖出 (-) | 5,600 | 13.06 | 73,136 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合